Bionpharma endeavors to bring quality generics to the market across therapeutic areas. For doing so we constantly evaluate products that can add value to all stake holders and the health‐Care system. This enables us to work on the development of these products and put them through the FDA approval process. Bionpharma is engaged In product development in different geographies across the World.

Milestones

Q4 2014

  • Bionpharma begins Operations on 1st November’2014.
  • License agreement signed with Pharmascience.
  • Initial equity funding.
  • State distribution license filing.
  • First Product put into development

Qtr 1 2015

  • Product development and manufacturing agreement signed with 2 CRO/CMO's.
  • Product licensing agreement signed with 2 partners.

Qtr 2 2015

  • 3rd Patry Logistic provider set up.
  • 2nd Round of financing completed.
  • Bionpharma Board constituted with 2 independent members.

Qtr 3 2015

  • State License in place for distributing commercial products.
  • Bionpharma Trademark registered
  • First commercial product Launched in September’2015.

Qtr 4 2015

  • Acquisition of Banner Generic business.
  • Equity funding by Athyrium capital completed.
  • Long term arrangement with a large CMO signed.
  • First in-house product filed with FDA.

Q1 2016

  • Bionpharma is fully commercial in all states.
  • First PIV filing by Bionpharma.
  • Approval of a product with 180 days exclusivity.

© 2015 All Right Reseved Bionpharma
HOME | ABOUT | PRODUCTS | PARTNERSHIP | CONSUMER INFORMATION | NEWS | TERMS OF USE | DISCLAIMER | CONTACT